LianBio - ADR

OTCPK:LIANY (USA)   ADR
$ 0.30 +0.0066 (+2.25%) 11:09 PM EST
At Loss
P/B:
0.16
Market Cap:
$ 31.73M
Enterprise V:
$ -217.65M
Volume:
140.97K
Avg Vol (2M):
1.27M
Volume:
140.97K
At Loss
Avg Vol (2M):
1.27M

Business Description

LianBio
NAICS : 325412 SIC : 2834
ISIN : US53000N1081

Share Class Description:

LIANY: ADR
Description
LianBio is a science-driven biopharmaceutical company dedicated to developing and commercializing medicines for patients with unmet medical needs, with an initial focus on in-licensing assets for Greater China and other Asian markets. It is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications.
Name Current Vs Industry Vs History
Cash-To-Debt 88.72
Equity-to-Asset 0.77
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y EPS without NRI Growth Rate -28.9

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 18.91
9-Day RSI 9.14
14-Day RSI 9.94
6-1 Month Momentum % -75.33
12-1 Month Momentum % -84.54

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.06
Quick Ratio 10.06
Cash Ratio 9.84

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 4.24
Name Current Vs Industry Vs History
ROE % -36.74
ROA % -29.02
ROIC % -589.49
ROC (Joel Greenblatt) % -1683.4
ROCE % -38.13

Financials (Next Earnings Date:2024-05-10 Est.)

LIANY's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:LIANY

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

LianBio Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.81
Beta 0
Volatility % 176.14
14-Day RSI 9.94
14-Day ATR ($) 0.122781
20-Day SMA ($) 0.314143
12-1 Month Momentum % -84.54
52-Week Range ($) 0.241 - 4.99
Shares Outstanding (Mil) 108.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

LianBio Filings

Filing Date Document Date Form
No Filing Data

LianBio Stock Events

Financials Calendars
Event Date Price($)
No Event Data

LianBio Frequently Asked Questions

What is LianBio(LIANY)'s stock price today?
The current price of LIANY is $0.30. The 52 week high of LIANY is $4.99 and 52 week low is $0.24.
When is next earnings date of LianBio(LIANY)?
The next earnings date of LianBio(LIANY) is 2024-05-10 Est..
Does LianBio(LIANY) pay dividends? If so, how much?
LianBio(LIANY) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1